+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure

Collegium Antropologicum 27(1): 181-187

Lispro insulin and metformin versus other combination in the diabetes mellitus type 2 management after secondary oral antidiabetic drug failure

The purpose of the study was to find out differences between treatments of diabetes type 2 after secondary oral antidiabetic drug failure. Three different methods of treatment were compared: lispro insulin in combination with metformin, glimepiride and metformin combination or two daily doses of biphasic insulin 30/70 together with bed-time NPH insulin. The study included 87 patients with diabetes mellitus type 2 randomly distributed into 3 different treatment groups. Fasting and postprandial glucose were analyzed by enzymatic colorimetric method and HbA1c was measured by ion exchange chromatography. HbA1c significantly decreased in all three study groups. The decrease was mostly expressed among patients treated with lispro and metformin. When focused on postprandial glucose control, antihyperglycemic metformin and insulin lispro therapy has greater impact on the overall metabolic control (decrease in level of HbA1c) in comparison with the above mentioned more traditional approaches.

Accession: 049479647

PMID: 12974145

Related references

Ross, S.A.; Zinman, B.; Campos, R.V.; Strack, T., 2002: A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents. To compare the effects of insulin lispro (LP) and human regular insulin (HR) when given twice daily with NPH insulin on glycemic control (HbA1c), daily blood glucose profiles and rates of hypoglycemia in patients with type 2 diabetes mellitus afte...

Janka, H.U.; Plewe, G.; Busch, K., 2007: Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus. OBJECTIVES: To compare initiation of insulin therapy by adding once-daily insulin glargine to oral antidiabetic agents (OADs) with switching patients to premixed 30% regular, 70% human neutral protamine hagedorn insulin (70/30) without OADs.DESIG...

Gamble, J.; Simpson, S.H.; Brown, L.C.; Johnson, J.A., 2008: Insulin versus an oral antidiabetic agent as add-on therapy in type 2 diabetes after failure of an oral antidiabetic regimen: a meta-analysis. Although evidence-based guidelines for the treatment of type 2 diabetes mellitus provide clear recommendations for initial therapy, evidence on an optimal treatment strategy after secondary failure is unclear. To compare the efficacy of add-on the...

Lundby-Christensen, L.; Tarnow, L.; Boesgaard, T.W.; Lund, Søren.S.; Wiinberg, N.; Perrild, H.; Krarup, T.; Snorgaard, O.; Gade-Rasmussen, B.; Thorsteinsson, B.; Røder, M.; Mathiesen, E.R.; Jensen, T.; Vestergaard, H.; Hedetoft, C.; Breum, L.; Duun, E.; Sneppen, S.B.; Pedersen, O.; Hemmingsen, B.; Carstensen, B.; Madsbad, S.; Gluud, C.; Wetterslev, Jørn.; Vaag, A.; Almdal, T.P., 2016: Metformin versus placebo in combination with insulin analogues in patients with type 2 diabetes mellitus-the randomised, blinded Copenhagen Insulin and Metformin Therapy (CIMT) trial. To assess the effect of metformin versus placebo both in combination with insulin analogue treatment on changes in carotid intima-media thickness (IMT) in patients with type 2 diabetes. Investigator-initiated, randomised, placebo-controlled trial...

Bastyr, E.J.IIi; Johnson, M.E.; Trautmann, M.E.; Anderson, J.H.Jr.; Vignati, L.; Ioce Study Group, 1999: Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure. This study assessed the safety profile and efficacy of a new combination therapy (insulin lispro plus sulfonylurea) in patients with type 2 diabetes mellitus experiencing secondary oral agent failure. A total of 423 patients were randomly assigned...

Browdos, R.; Schwartz, S.; Stuart, C.A.; Zagar, A.; Graf, C.J.; Bastyr, E.J.; Ioez Study Group, 1999: Combination of insulin lispro , metformin , or bedtime NPH with sulfonylurea following secondary SU failure. Diabetes 48(SUPPL 1): A104

Buse, J.B.; Wolffenbuttel, B.H.R.; Herman, W.H.; Shemonsky, N.K.; Jiang, H.H.; Fahrbach, J.L.; Scism-Bacon, J.L.; Martin, S.A., 2009: DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes. To compare the ability of two starter insulin regimens to achieve glycemic control in a large, ethnically diverse population with type 2 diabetes. During the initiation phase of the DURABLE trial, patients were randomized to a twice-daily lispro m...

Jeong, I-Kyung.; Chung, C.Hee.; Zhou, Z.; Han, J.Hee.; Duan, R.; Edralin, D.M.; Rodriguez, A., 2016: Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus. This analysis evaluated efficacy and safety of insulin lispro low mixture (LM25) twice daily (breakfast and dinner) versus basal insulin glargine (bedtime) plus prandial insulin lispro (IGL) once daily before the largest meal in East Asian (EA) an...

Mirouze, J.; Augustin-Pascalis, I., 1988: Secondary failure of oral antidiabetic and dietetic therapy in non-insulin-dependent diabetes mellitus. Remission through short sessions of continuous intravenous insulin infusion. The infusion of periodic intravenous insulin for the equilibrium of the diabetic state is proposed for cases of non-insulin-dependent diabetes mellitus (NIDDM) that have become resistant to oral treatment. In order to re-establish the efficacy of...

Strojek, K.; Polaszewska Muszynska, M.; Krassowski, J.; Gumprecht, J.; Rudzki, H.; Olejniczak, H.; Nazar, M., 2003: Repaglinide versus sulfonylurea in combination with bedtime NPH insulin in patients with type 2 diabetes with secondary failure to oral treatment. Diabetes 52(Supplement 1): A135